Tango Therapeutics is a biotechnology company developing novel medicines. Founded by Alan Ashworth, Jose Baselga, and Timothy Lu in 2017, Tango Therapeutics is backed by investors that include Boxer Capital, Casdin Capital, and Cormorant Asset Management and is headquartered in Cambridge.